Reading’s location on Route 93 north of the I-95/128 interchange places it in a practical geography for life sciences companies, healthcare services, and specialty manufacturing operations that benefit from excellent highway access to both the Greater Boston market and the Route 128 / Route 3 corridors. The town’s commercial districts have attracted a growing number of medical offices, specialty manufacturing tenants, and life sciences support services.

Reading’s manufacturing base includes Analogic Corporation, a global leader in medical imaging and detection technology supporting both healthcare and security applications. Bioreliance, part of Merck’s biosafety testing and biologics services network, serves pharmaceutical and biotech clients across the Reading/Woburn/Burlington cluster. And Microfluidics International Corporation manufactures high-shear fluid processing equipment used in pharmaceutical formulation and cGMP biomanufacturing worldwide — proof that Reading’s life sciences footprint extends well beyond medical offices.

As the Route 93 north corridor develops as a secondary life sciences address — extending Greater Boston’s biotech ecosystem northward — Reading has emerged as a practical operating location for growing companies seeking modern facilities and workforce access without Route 128 congestion. CleanTech Systems’ coverage extends along the full Route 93 corridor with the same account-level management applied at our largest accounts.